lactic acid has been researched along with clofazimine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fearon, KC; Plumb, JA; Sri-Pathmanathan, RM | 1 |
Gangadharam, PR; Kailasam, S; Wise, DL | 1 |
Barreiros, L; Chaves, LL; Costa Lima, SA; Ferreira, D; Reis, S; Sarmento, B; Segundo, MA; Vieira, ACC | 1 |
5 other study(ies) available for lactic acid and clofazimine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung-cancer cell line in vitro and in vivo.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Carcinoma, Non-Small-Cell Lung; Cell Division; Clofazimine; Drug Screening Assays, Antitumor; Humans; Lactates; Lactic Acid; Lung Neoplasms; Mice; Mice, Nude; Oxygen Consumption; Tumor Cells, Cultured | 1994 |
Bioavailability and chemotherapeutic activity of clofazimine against Mycobacterium avium complex infections in beige mice following a single implant of a biodegradable polymer.
Topics: Animals; Biological Availability; Clofazimine; Drug Implants; Lactic Acid; Liver; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium-intracellulare Infection; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 1994 |
Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Clofazimine; HT29 Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Lactic Acid; Nanoparticles; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2018 |